August 2021 FDA Recall Oxycodone Hydrochloride by Rhodes Pharmaceuticals, L.p.
D-0794-2021 - Presence of Foreign Tablets/Capsules; A single foreign tablet Hydrochlorothiazide/Lisinopril 25/20 was found in one bottle
This Class II drug recall was voluntarily initiated by Rhodes Pharmaceuticals, L.p. on August 19, 2021 for the product Oxycodone Hydrochloride. The FDA reported the reason for recall as presence of foreign tablets/capsules; a single foreign tablet hydrochlorothiazide/lisinopril 25/20 was found in one bottle. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-0794-2021
Presence of Foreign Tablets/Capsules; A single foreign tablet Hydrochlorothiazide/Lisinopril 25/20 was found in one bottle
08-19-2021
09-22-2021
55,344/100 count bottles
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Rhodes Pharmaceuticals, L.P.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Product was distributed nationwide.
03-07-2023
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Oxycodone Hydrochloride Tablets, USP, 10 mg, 100 count bottle, Rx only, Marketed by: Rhodes Pharmaceuticals L.P., Coventry RI 02816, Manufactured by: Purdue Pharma L.P., Stanford, CT 06901 NDC 42858-002-01
Batch or Lot Expiration Information
Lot# WP5K0Y, exp. date 02/28/2023